Search Results
61 results found-
ToVs solely related to over-the-counter medicines - ToVs excluded from the scope of the EFPIA Disclosure Code, such as informational and educational materials, items of medical utility, food and beverage, medical samples - Fees charged by logistics agencies assisting in organising travel and meetings -
https://www.csl.com/-/media/shared/documents/vifor-disclosures/methodological-notes/methodological-note-ireland-2021.pdf -
CSL Innovation Pty Ltd Australia 100 CSL Behring (Australia) Pty Ltd Australia 100 CSL Behring LLC USA 100 CSL Plasma Inc USA 100 CSL Behring GmbH Germany 100 CSL Behring AG Switzerland 100 CSL Behring Lengnau AG Switzerland 100 CSLB Holdings Inc USA 100 CSL Finance Plc UK 100 CSL Finance Pty Ltd Australia 100 CSL Behring Holdings Limited UK 100 CSL Behring (Holdings) Pty Ltd Australia 100 Seqirus UK Limited UK 100 Seqirus Pty Ltd Australia 100 Seqirus Vaccines Limited UK 100 Seqirus USA Inc USA 100 Seqirus Inc USA 100 Vifor Pharma Participations Ltd Switzerland 100 Vifor (International) Ltd Switzerland 100 Vifor Fresenius Medical Care Renal Pharma Ltd Switzerland 55 *
https://www.csl.com/-/media/one-csl/sustainability/data-and-reporting-centre/documents/csl-limited-tax-transparency-report-2022-23.pdf -
ToVs solely related to over-the-counter medicines - ToVs excluded from the scope of the EFPIA Disclosure Code, such as informational and educational materials, items of medical utility, food and beverage, medical samples - Fees charged by logistics agencies assisting in organising travel and meetings -
https://www.csl.com/-/media/shared/documents/vifor-disclosures/methodological-notes/methodological-note_2022_ch.pdf -
Numerous meetings were held with Italian and Spanish regional governments on the burden of influenza, available products, and the need to increase immunisation rates, improve public health outcomes, and decrease costs especially for at-risk individuals over 65 years of age.
https://www.csl.com/-/media/csl/corporate-responsibility-reports/csl-limited-corporate-responsibility-report-2018.pdf -
Haemophilia and AFSTYLA Australia, Austria, Belgium, Bulgaria, Canada, Croatia, Cyprus, Czech Republic, Denmark, Estonia, coagulation products Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Support and enhance plasma products and develop a novel Sweden, Switzerland, UK recombinant portfolio with a focus on scientific product innovation and patient benefit HAEMATE® P Iraq, Tunisia, Uzbekistan
https://www.csl.com/-/media/csl/corporate-responsibility-reports/csl-limited-corporate-responsibility-report-2017.pdf -
CSL Innovation Pty Ltd Australia 100 CSL Behring (Australia) Pty Ltd Australia 100 CSL Behring LLC USA 100 CSL Plasma Inc USA 100 CSL Behring GmbH Germany 100 CSL Behring AG Switzerland 100 CSL Behring Lengnau AG Switzerland 100 CSLB Holdings Inc USA 100 CSL Finance Plc UK 100 CSL Finance Pty Ltd Australia 100 Seqirus UK Limited UK 100 Seqirus Pty Ltd Australia 100 Seqirus Vaccines Limited UK 100 Seqirus USA Inc USA 100 Seqirus Inc USA 100 *
https://www.csl.com/-/media/one-csl/sustainability/data-and-reporting-centre/documents/csl-limited-tax-transparency-report-2021-22.pdf -
ToVs solely related to over-the-counter medicines - ToVs excluded from the scope of the EFPIA Disclosure Code, such as informational and educational materials, items of medical utility, food and beverage, medical samples - Fees charged by logistics agencies assisting in organising travel and meetings -
https://www.csl.com/-/media/shared/documents/vifor-disclosures/methodological-notes/methodological-note-romania-2021.pdf -
ToVs solely related to over-the-counter medicines - ToVs excluded from the scope of the EFPIA Disclosure Code, such as informational and educational materials, items of medical utility, food and beverage, medical samples - Fees charged by logistics agencies assisting in organising travel and meetings -
https://www.csl.com/-/media/shared/documents/vifor-disclosures/methodological-notes/methodological-note-switzerland-2021.pdf -
Intended Audience This press release is issued from CSL Seqirus in Summit, New Jersey, USA and is intended to provide information about our global business.
https://newsroom.csl.com/2023-09-15-CSL-Seqirus-to-Present-at-9th-ESWI-Conference-on-the-Burden-of-Influenza-and-Impact-of-Vaccination-on-Public-Health